Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers
A. Oberthuer, D. Juraeva, B. Hero, R. Volland, C. Sterz, R. Schmidt, A. Faldum, Y. Kahlert, A. Engesser, S. Asgharzadeh, R. Seeger, M. Ohira, A. Nakagawara, P. Scaruffi, G. P. Tonini, I. Janoueix-Lerosey, O. Delattre, G. Schleiermacher, J. Vandesompele, F. Speleman, R. Noguera, M. Piqueras, J. Benard, A. Valent, S. Avigad, I. Yaniv, R. G. Grundy, M. Ortmann, C. Shao, M. Schwab, R. Eils, T. Simon, J. Theissen, F. Berthold, F. Westermann, B. Brors, M. Fischer
September 2014